Prosthetic heart valve

Circulation

Volumn 123, Issue 22, 2011, Pages 2602-2605

  Huang, Grace ^a   Rahimtoola, Shahbudin H ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b LAC USC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; WARFARIN;

ANGIOCARDIOGRAPHY; ANTICOAGULANT THERAPY; AORTA RECONSTRUCTION; AORTA STENOSIS; AORTA VALVE PROSTHESIS; AORTA VALVE REPLACEMENT; ARTICLE; BODY MASS; BODY SURFACE; CARPENTIER EDWARDS BIOPROSTHESIS; CLINICAL PRACTICE; DETERIORATION; DIET RESTRICTION; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; DRUG TOLERABILITY; FOLLOW UP; GENETIC VARIABILITY; HEART CATHETERIZATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HUMAN; INTERNATIONAL NORMALIZED RATIO; LONG TERM CARE; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTHETIC VALVE THROMBOSIS; PULMONARY HYPERTENSION; SURVIVAL; THROMBOEMBOLISM;

AORTIC VALVE; AORTIC VALVE STENOSIS; BIOPROSTHESIS; HEART VALVE PROSTHESIS; HUMANS; MALE; MIDDLE AGED;

EID: 79958803490     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.110.979518     Document Type: Article

References (10)

1. Rahimtoola SH. Choice of prosthetic heart valve in adults: an update. J Am Coll Cardiol. 2010;55:2413-2426.
2. Sharma S, Mehra A, Rahimtoola SH. Valvular heart disease: a century of progress. Am J Med. 2008;121:664-673.
3. Rankin JS, Hammill BG, Ferguson TBJ, Glower DD, O'Brien SM, DeLong ER, Peterson ED, Edwards FH. Determinants of operative mortality in valvular heart surgery. J Thorac Cardiovasc Surg. 2006;131: 547-557.
4. Takkenberg JJM, Klieverik LMA, Schoof PH, van Suylen RJ, van Herwerden LA, Zondervan PE, Roos-Hesselink JW, Eijkemans MJC, Yacoub MH, Bogers AJJC. The Ross procedure: a systemic review and meta-analysis. Circulation. 2009;119: 222-228.
5. Oxenham H, Bloomfield P, Wheatley DJ, Lee RJ, Cunningham J, Prescott RJ, Miller HC. Twenty year comparison of a Bjork- Shiley mechanical heart valve with porcine bioprosthesis. Heart. 2003;89:715-721. (Pubitemid 36760624)
6. Hammermeister K, Sethi GK, Henderson WG, Grover FL, Oprian C, Rahimtoola SH. Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs randomized trial. J Am Coll Cardiol. 2000; 36:1152-1158.
7. Rahimtoola SH. Choice of prosthetic heart valve for adult patients. J Am Coll Cardiol. 2003;41:893-904. (Pubitemid 36315528)
8. van Geldorp MWA, Jamieson WRE, Kappetein AP, Ye J, Fradet GJ, Eijkemans MJC, Grunkemeier GL, Bogers AJJC, Takkenberg JJM. Patient outcome after aortic valve replacement with a mechanical or biological prosthesis: weighing lifetime anticoagulantrelated event risk against reoperation risk. J Thorac Cardiovasc Surg. 2009;137: 881-886.
9. Schelbert EB, Vaughan-Sarrazin MS, Welke KF, Rosenthal GE. Valve type and long-term outcomes after aortic valve replacement in older patients. Heart. 2008;94:1181-1188.
10. Lloyd-Jonnes DM, Leip EP, Larson MG, D'Agostino RB, Beiser A, Wilson PW, Wolf PA, Levy D. Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age. Circulation. 2006;113: 791-798.